Contribution of human lung parenchyma and leukocyte influx to oxidative stress and immune systemmediated pathology following Nipah virus infection

Journal of Virology

Volumn 91, Issue 15, 2017, Pages

  Escaffre, Olivier ^a   Saito, Tais B ^a   Juelich, Terry L ^a   Ikegami, Tetsuro ^a   Smith, Jennifer K ^a   Perez, David D ^a   Atkins, Colm ^a   Levine, Corri B ^b   Huante, Matthew B ^a   Nusbaum, Rebecca J ^a   Endsley, Janice J ^a   Freiberg, Alexander N ^a,b   Rockx, Barry ^a,c  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Antioxidant therapies; Henipavirus; Human lung grafts; Humanized mouse; Inflammatory response; Oxidative stress; Virus replication

Indexed keywords

CHEMOKINE; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CYTOPATHOGENIC EFFECT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; LEUKOCYTE MIGRATION; LUNG INFECTION; LUNG PARENCHYMA; LUNG TRANSPLANTATION; MOUSE; NIPAH VIRUS INFECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS PATHOGENESIS; VIRUS REPLICATION; ACUTE LUNG INJURY; ANIMAL; DISEASE MODEL; GROWTH, DEVELOPMENT AND AGING; HENIPAVIRUS INFECTION; IMMUNOLOGY; LEUKOCYTE; LUNG; NIPAH VIRUS; PATHOLOGY; SCID MOUSE;

ACUTE LUNG INJURY; ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; HENIPAVIRUS INFECTIONS; HUMANS; LEUKOCYTES; LUNG; MICE; MICE, SCID; NIPAH VIRUS; OXIDATIVE STRESS;

EID: 85023207561     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00275-17     Document Type: Article

References (63)

1. Eaton BT, Broder CC, Wang LF. 2005. Hendra and Nipah viruses: pathogenesis and therapeutics. Curr Mol Med 5:805-816. https://doi.org/10.2174/156652405774962308
2. Hooper P, Zaki S, Daniels P, Middleton D. 2001. Comparative pathology of the diseases caused by Hendra and Nipah viruses. Microbes Infect 3:315-322. https://doi.org/10.1016/S1286-4579(01)01385-5
3. Chua KB, Lam SK, Goh KJ, Hooi PS, Ksiazek TG, Kamarulzaman A, Olson J, Tan CT. 2001. The presence of Nipah virus in respiratory secretions and urine of patients during an outbreak of Nipah virus encephalitis in Malaysia. J Infect 42:40-43. https://doi.org/10.1053/jinf.2000.0782
4. Goh KJ, Tan CT, Chew NK, Tan PS, Kamarulzaman A, Sarji SA, Wong KT, Abdullah BJ, Chua KB, Lam SK. 2000. Clinical features of Nipah virus encephalitis among pig farmers in Malaysia. N Engl J Med 342: 1229-1235. https://doi.org/10.1056/NEJM200004273421701
5. Mounts AW, Kaur H, Parashar UD, Ksiazek TG, Cannon D, Arokiasamy JT, Anderson LJ, Lye MS. 2001. A cohort study of health care workers to assess nosocomial transmissibility of Nipah virus, Malaysia, 1999. J Infect Dis 183:810-813. https://doi.org/10.1086/318822
6. Harit AK, Ichhpujani RL, Gupta S, Gill KS, Lal S, Ganguly NK, Agarwal SP. 2006. Nipah/Hendra virus outbreak in Siliguri, West Bengal, India in 2001. Indian J Med Res 123:553-560
7. Hossain MJ, Gurley ES, Montgomery JM, Bell M, Carroll DS, Hsu VP, Formenty P, Croisier A, Bertherat E, Faiz MA, Azad AK, Islam R, Molla MA, Ksiazek TG, Rota PA, Comer JA, Rollin PE, Luby SP, Breiman RF. 2008. Clinical presentation of Nipah virus infection in Bangladesh. Clin Infect Dis 46:977-984. https://doi.org/10.1086/529147
8. Lo MK, Rota PA. 2008. The emergence of Nipah virus, a highly pathogenic paramyxovirus. J Clin Virol 43:396-400. https://doi.org/10.1016/j.jcv.2008.08.007
9. Clayton BA, Middleton D, Bergfeld J, Haining J, Arkinstall R, Wang L, Marsh GA. 2012. Transmission routes for Nipah virus from Malaysia and Bangladesh. Emerg Infect Dis 18:1983-1993. https://doi.org/10.3201/ eid1812.120875
10. DeBuysscher BL, de Wit E, Munster VJ, Scott D, Feldmann H, Prescott J. 2013. Comparison of the pathogenicity of Nipah virus isolates from Bangladesh and Malaysia in the Syrian hamster. PLoS Negl Trop Dis 7:e2024. https://doi.org/10.1371/journal.pntd.0002024
11. Escaffre O, Borisevich V, Carmical JR, Prusak D, Prescott J, Feldmann H, Rockx B. 2013. Henipavirus pathogenesis in human respiratory epithelial cells. J Virol 87:3284-3294. https://doi.org/10.1128/JVI.02576-12
12. Escaffre O, Borisevich V, Vergara LA, Wen JW, Long D, Rockx B. 2016. Characterization of Nipah virus infection in a model of human airway epithelial cells cultured at an air-liquid interface. J Gen Virol 97: 1077-1086. https://doi.org/10.1099/jgv.0.000441
13. Mire CE, Satterfield BA, Geisbert JB, Agans KN, Borisevich V, Yan L, Chan YP, Cross RW, Fenton KA, Broder CC, Geisbert TW. 2016. Pathogenic differences between Nipah virus Bangladesh and Malaysia strains in primates: implications for antibody therapy. Sci Rep 6:30916. https://doi.org/10.1038/srep30916
14. Wong KT, Shieh WJ, Kumar S, Norain K, Abdullah W, Guarner J, Goldsmith CS, Chua KB, Lam SK, Tan CT, Goh KJ, Chong HT, Jusoh R, Rollin PE, Ksiazek TG, Zaki SR. 2002. Nipah virus infection: pathology and pathogenesis of an emerging paramyxoviral zoonosis. Am J Pathol 161: 2153-2167. https://doi.org/10.1016/S0002-9440(10)64493-8
15. Valbuena G, Halliday H, Borisevich V, Goez Y, Rockx B. 2014. A human lung xenograft mouse model of Nipah virus infection. PLoS Pathog 10:e1004063. https://doi.org/10.1371/journal.ppat.1004063
16. Baseler L, de Wit E, Scott DP, Munster VJ, Feldmann H. 2015. Syrian hamsters (Mesocricetus auratus) oronasally inoculated with a Nipah virus isolate from Bangladesh or Malaysia develop similar respiratory tract lesions. Vet Pathol 52:38-45. https://doi.org/10.1177/0300985814556189
17. Clayton BA, Middleton D, Arkinstall R, Frazer L, Wang LF, Marsh GA. 2016. The nature of exposure drives transmission of Nipah viruses from Malaysia and Bangladesh in ferrets. PLoS Negl Trop Dis 10:e0004775. https://doi.org/10.1371/journal.pntd.0004775
18. Rockx B, Brining D, Kramer J, Callison J, Ebihara H, Mansfield K, Feldmann H. 2011. Clinical outcome of henipavirus infection in hamsters is determined by the route and dose of infection. J Virol 85:7658-7671. https:// doi.org/10.1128/JVI.00473-11
19. Escaffre O, Halliday H, Borisevich V, Casola A, Rockx B. 2015. Oxidative stress in Nipah virus-infected human small airway epithelial cells. J Gen Virol 96:2961-2970. https://doi.org/10.1099/jgv.0.000243
20. Escaffre O, Borisevich V, Rockx B. 2013. Pathogenesis of Hendra and Nipah virus infection in humans. J Infect Dev Ctries 7:308-311. https:// doi.org/10.3855/jidc.3648
21. Berges BK, Rowan MR. 2011. The utility of the new generation of humanized mice to study HIV-1 infection: transmission, prevention, pathogenesis, and treatment. Retrovirology 8:65. https://doi.org/10.1186/1742-4690-8-65
22. Bird BH, Spengler JR, Chakrabarti AK, Khristova ML, Sealy TK, Coleman-McCray JD, Martin BE, Dodd KA, Goldsmith CS, Sanders J, Zaki SR, Nichol ST, Spiropoulou CF. 2016. Humanized mouse model of Ebola virus disease mimics the immune responses in human disease. J Infect Dis 213:703-711. https://doi.org/10.1093/infdis/jiv538
23. Calderon VE, Valbuena G, Goez Y, Judy BM, Huante MB, Sutjita P, Johnston RK, Estes DM, Hunter RL, Actor JK, Cirillo JD, Endsley JJ. 2013. A humanized mouse model of tuberculosis. PLoS One 8:e63331. https:// doi.org/10.1371/journal.pone.0063331
24. Lee J, Brehm MA, Greiner D, Shultz LD, Kornfeld H. 2013. Engrafted human cells generate adaptive immune responses to Mycobacterium bovis BCG infection in humanized mice. BMC Immunol 14:53. https:// doi.org/10.1186/1471-2172-14-53
25. Morton JJ, Bird G, Refaeli Y, Jimeno A. 2016. Humanized mouse xenograft models: narrowing the tumor-microenvironment gap. Cancer Res 76:6153-6158. https://doi.org/10.1158/0008-5472.CAN-16-1260
26. Nusbaum RJ, Calderon VE, Huante MB, Sutjita P, Vijayakumar S, Lancaster KL, Hunter RL, Actor JK, Cirillo JD, Aronson J, Gelman BB, Lisinicchia JG, Valbuena G, Endsley JJ. 2016. Pulmonary tuberculosis in humanized mice infected with HIV-1. Sci Rep 6:21522. https://doi.org/10.1038/srep21522
27. Smith DJ, Lin LJ, Moon H, Pham AT, Wang X, Liu S, Ji S, Rezek V, Shimizu S, Ruiz M, Lam J, Janzen DM, Memarzadeh S, Kohn DB, Zack J, Kitchen SG, An DS, Yang L. 2016. Propagating humanized BLT mice for the study of human immunology and immunotherapy. Stem Cells Dev 25: 1863-1873. https://doi.org/10.1089/scd.2016.0193
28. Spengler JR, Lavender KJ, Martellaro C, Carmody A, Kurth A, Keck JG, Saturday G, Scott DP, Nichol ST, Hasenkrug KJ, Spiropoulou CF, Feldmann H, Prescott J. 2016. Ebola virus replication and disease without immunopathology in mice expressing transgenes to support human myeloid and lymphoid cell engraftment. J Infect Dis 214(Suppl 3): S308-S318. https://doi.org/10.1093/infdis/jiw248
29. Lo MK, Miller D, Aljofan M, Mungall BA, Rollin PE, Bellini WJ, Rota PA. 2010. Characterization of the antiviral and inflammatory responses against Nipah virus in endothelial cells and neurons. Virology 404: 78-88. https://doi.org/10.1016/j.virol.2010.05.005
30. Gurley ES, Montgomery JM, Hossain MJ, Bell M, Azad AK, Islam MR, Molla MA, Carroll DS, Ksiazek TG, Rota PA, Lowe L, Comer JA, Rollin P, Czub M, Grolla A, Feldmann H, Luby SP, Woodward JL, Breiman RF. 2007. Personto-person transmission of Nipah virus in a Bangladeshi community. Emerg Infect Dis 13:1031-1037. https://doi.org/10.3201/eid1307.061128
31. Wirblich C, Schnell MJ. 2011. Rabies virus (RV) glycoprotein expression levels are not critical for pathogenicity of RV. J Virol 85:697-704. https:// doi.org/10.1128/JVI.01309-10
32. Baseler L, Scott DP, Saturday G, Horne E, Rosenke R, Thomas T, Meade-White K, Haddock E, Feldmann H, de Wit E. 2016. Identifying early target cells of Nipah virus infection in Syrian hamsters. PLoS Negl Trop Dis 10:e0005120. https://doi.org/10.1371/journal.pntd.0005120
33. Fujisawa H. 2001. Inhibitory role of neutrophils on influenza virus multiplication in the lungs of mice. Microbiol Immunol 45:679-688. https:// doi.org/10.1111/j.1348-0421.2001.tb01302.x
34. Fujisawa H. 2008. Neutrophils play an essential role in cooperation with antibody in both protection against and recovery from pulmonary infection with influenza virus in mice. J Virol 82:2772-2783. https://doi.org/10.1128/JVI.01210-07
35. Narasaraju T, Yang E, Samy RP, Ng HH, Poh WP, Liew AA, Phoon MC, van Rooijen N, Chow VT. 2011. Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis. Am J Pathol 179:199-210. https://doi.org/10.1016/j.ajpath.2011.03.013
36. de Vries RD, Yuksel S, Osterhaus AD, de Swart RL. 2010. Specific CD8(+) T-lymphocytes control dissemination of measles virus. Eur J Immunol 40:388-395. https://doi.org/10.1002/eji.200939949
37. Frey S, Krempl CD, Schmitt-Graff A, Ehl S. 2008. Role of T cells in virus control and disease after infection with pneumonia virus of mice. J Virol 82:11619-11627. https://doi.org/10.1128/JVI.00375-08
38. Janeway C, Travers P, Walport M, Shlomchik M. 2004. Immunobiology: the immune system in health and disease, 6th ed. Garland Science, New York, NY
39. Bangs SC, McMichael AJ, Xu XN. 2006. Bystander T cell activation- implications for HIV infection and other diseases. Trends Immunol 27: 518-524. https://doi.org/10.1016/j.it.2006.09.006
40. Unutmaz D, Pileri P, Abrignani S. 1994. Antigen-independent activation of naive and memory resting T cells by a cytokine combination. J Exp Med 180:1159-1164. https://doi.org/10.1084/jem.180.3.1159
41. + T cells in vivo by IL-15. Immunity 8:591-599. https://doi.org/10.1016/S1074-7613(00)80564-6
42. Doyle IR, Nicholas TE, Bersten AD. 1999. Partitioning lung and plasma proteins: circulating surfactant proteins as biomarkers of alveolocapillary permeability. Clin Exp Pharmacol Physiol 26:185-197. https://doi.org/10.1046/j.1440-1681.1999.03015.x
43. Hermans C, Bernard A. 1999. Lung epithelium-specific proteins: characteristics and potential applications as markers. Am J Respir Crit Care Med 159:646-678. https://doi.org/10.1164/ajrccm.159.2.9806064
44. Maisner A, Neufeld J, Weingartl H. 2009. Organ-and endotheliotropism of Nipah virus infections in vivo and in vitro. Thromb Haemost 102: 1014-1023. https://doi.org/10.1160/TH09-05-0310
45. Wong KT, Shieh WJ, Zaki SR, Tan CT. 2002. Nipah virus infection, an emerging paramyxoviral zoonosis. Springer Semin Immunopathol 24: 215-228. https://doi.org/10.1007/s00281-002-0106-y
46. Bossart KN, Rockx B, Feldmann F, Brining D, Scott D, LaCasse R, Geisbert JB, Feng YR, Chan YP, Hickey AC, Broder CC, Feldmann H, Geisbert TW. 2012. A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge. Sci Transl Med 4:146ra107. https://doi.org/10.1126/scitranslmed.3004241
47. Ayala A, Munoz MF, Arguelles S. 2014. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev 2014:360438. https://doi.org/10.1155/2014/360438
48. Castro SM, Guerrero-Plata A, Suarez-Real G, Adegboyega PA, Colasurdo GN, Khan AM, Garofalo RP, Casola A. 2006. Antioxidant treatment ameliorates respiratory syncytial virus-induced disease and lung inflammation. Am J Respir Crit Care Med 174:1361-1369. https://doi.org/10.1164/ rccm.200603-319OC
49. Giera M, Lingeman H, Niessen WM. 2012. Recent advancements in the LC-and GC-based analysis of malondialdehyde (MDA): a brief overview. Chromatographia 75:433-440. https://doi.org/10.1007/s10337-012-2237-1
50. DeBuysscher BL, Scott D, Marzi A, Prescott J, Feldmann H. 2014. Singledose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies directed against surface glycoproteins. Vaccine 32: 2637-2644. https://doi.org/10.1016/j.vaccine.2014.02.087
51. Mohd Nor MN, Gan CH, Ong BL. 2000. Nipah virus infection of pigs in peninsular Malaysia. Rev Sci Tech 19:160-165. https://doi.org/10.20506/ rst.19.1.1202
52. Yoneda M, Georges-Courbot MC, Ikeda F, Ishii M, Nagata N, Jacquot F, Raoul H, Sato H, Kai C. 2013. Recombinant measles virus vaccine expressing the Nipah virus glycoprotein protects against lethal Nipah virus challenge. PLoS One 8:e58414. https://doi.org/10.1371/journal.pone.0058414
53. Ichikawa A, Kuba K, Morita M, Chida S, Tezuka H, Hara H, Sasaki T, Ohteki T, Ranieri VM, dos Santos CC, Kawaoka Y, Akira S, Luster AD, Lu B, Penninger JM, Uhlig S, Slutsky AS, Imai Y. 2013. CXCL10-CXCR3 enhances the development of neutrophil-mediated fulminant lung injury of viral and nonviral origin. Am J Respir Crit Care Med 187:65-77. https://doi.org/10.1164/rccm.201203-0508OC
54. Wright HL, Moots RJ, Bucknall RC, Edwards SW. 2010. Neutrophil function in inflammation and inflammatory diseases. Rheumatology (Oxford) 49:1618-1631. https://doi.org/10.1093/rheumatology/keq045
55. McGovern TK, Chen M, Allard B, Larsson K, Martin JG, Adner M. 2016. Neutrophilic oxidative stress mediates organic dust-induced pulmonary inflammation and airway hyperresponsiveness. Am J Physiol Lung Cell Mol Physiol 310:L155-L165. https://doi.org/10.1152/ajplung.00172.2015
56. McGovern TK, Goldberger M, Allard B, Farahnak S, Hamamoto Y, O'Sullivan M, Hirota N, Martel G, Rousseau S, Martin JG. 2015. Neutrophils mediate airway hyperresponsiveness after chlorine-induced airway injury in the mouse. Am J Respir Cell Mol Biol 52:513-522. https://doi.org/10.1165/rcmb.2013-0430OC
57. Kamanaka M, Kim ST, Wan YY, Sutterwala FS, Lara-Tejero M, Galan JE, Harhaj E, Flavell RA. 2006. Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse. Immunity 25:941-952. https://doi.org/10.1016/j.immuni.2006.09.013
58. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. 2001. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19: 683-765. https://doi.org/10.1146/annurev.immunol.19.1.683
59. Couper KN, Blount DG, Riley EM. 2008. IL-10: the master regulator of immunity to infection. J Immunol 180:5771-5777. https://doi.org/10.4049/jimmunol.180.9.5771
60. Joss A, Akdis M, Faith A, Blaser K, Akdis CA. 2000. IL-10 directly acts on T cells by specifically altering the CD28 co-stimulation pathway. Eur J Immunol 30:1683-1690. https://doi.org/10.1002/1521-4141(200006)30:6<1683::AIDIMMU1683>3.0.CO;2-A
61. Schandene L, Cogan E, Crusiaux A, Goldman M. 1997. Interferon-alpha upregulates both interleukin-10 and interferon-gamma production by human CD4+ T cells. Blood 89:1110-1111
62. Sun J, Madan R, Karp CL, Braciale TJ. 2009. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat Med 15:277-284. https://doi.org/10.1038/nm.1929
63. Code of Federal Regulations. 2009. Title 45. Public welfare. Part 46. Protection of human subjects. https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/